As of today (2024-04-29), Alliance Pharma's share price is £0.3495.
Alliance Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.05. Hence, Alliance Pharma's Price-to-Free-Cash-Flow Ratio for today is 6.59.
The historical rank and industry rank for Alliance Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:
LSE:APH'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.59 Med: 15.22 Max: 22.13
Current: 6.59
During the past 13 years, Alliance Pharma's highest Price-to-Free-Cash-Flow Ratio was 22.13. The lowest was 6.59. And the median was 15.22.
LSE:APH's Price-to-Free-Cash-Flow is ranked better than 87.45% of 494
companies
in the Drug Manufacturers industry
Industry Median: 22.08
vs LSE:APH: 6.59
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Alliance Pharma was -8.60% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -14.90% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -0.10% per year.
During the past 13 years, Alliance Pharma's highest 3-Year average Free Cash Flow per Share Growth Rate was 74.90% per year. The lowest was -108.00% per year. And the median was 19.60% per year.
Alliance Pharma Price-to-Free-Cash-Flow Historical Data
The historical data trend for Alliance Pharma's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Alliance Pharma's Price-to-Free-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alliance Pharma's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Alliance Pharma's Price-to-Free-Cash-Flow falls into.
Alliance Pharma's Share Price of today is £0.3495.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alliance Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Alliance Pharma Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Alliance Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:APH has been successfully added to your 